delisting
New resource for diabetes after difficult 1 July changes
Following the bumpy 1 July introduction of changes to the NDSS, South Australian Diabetes Educator Jayne Lehman and pharmacy consultant Kos Sclavos have launched a new resource for educators and …
Dodgy CAM Claims: where does the hype end and health fraud begin?
Pharmacy has a lot to learn from the Sensaslim debacle—but is it interested in doing so? wonders Ian Carr A short few years ago, one Groundhog Day in the diet …
Panadol Osteo to stay delisted
The PBAC has reaffirmed its decision that Panadol Osteo should be delisted. “The PBAC assessed the issues raised in the correspondence, but did not consider that there was any basis …
Many pharmacies not choosing to discount $1: Quilty
While the second half of 2015 was positive for pharmacies, 2016 will be challenging with the further PBS reforms reducing wholesaler and generic trading terms, says Guild executive director David …
The $1 Christmas gift you didn’t want
The $1 pharmacy co-payment discount is about as welcome as a lump of coal in a Christmas stocking for many pharmacists, writes Mal Scrymgeour… is your strategy in place yet? …
Consumers encouraged to talk to pharmacists on delistings: NPS
As the end of 2015 nears, NPS MedicineWise has joined other stakeholders in encouraging Australians who are prescribed OTC medicines to talk to their pharmacists and doctors about how the …
Discounting, delisting to affect Safety Net: Guild
All Australians need to be aware of the impact that Federal Government changes to the PBS will have on the number of prescriptions they will need to fill in order …
Medicines delisting: the PBAC principles
To guide its decisions on medicines delisting including those available OTC, the Department of Health has published principles set by the Pharmaceutical Benefits Advisory Committee. The delisting principles considered appropriate …